Submission Details
| 510(k) Number | K972331 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 23, 1997 |
| Decision Date | August 01, 1997 |
| Days to Decision | 39 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K972331 is an FDA 510(k) clearance for the INNOFLUOR GENTAMICIN ASSAY SYSTEM, a Fluorescence Polarization Immunoassay, Phenobarbital (Class II — Special Controls, product code LGQ), submitted by Oxis Intl., Inc. (Portland, US). The FDA issued a Cleared decision on August 1, 1997, 39 days after receiving the submission on June 23, 1997. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3660.
| 510(k) Number | K972331 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 23, 1997 |
| Decision Date | August 01, 1997 |
| Days to Decision | 39 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | LGQ — Fluorescence Polarization Immunoassay, Phenobarbital |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3660 |